Once-Daily Integrase Inhibitor (Insti) With Boosted Darunavir is Non-Inferior to Standard of Care in Virogically Suppressed Children, Week 48 Results of the Smile PENTA-17 Trial

Topics

A. Compagnucci Reviews in Antiviral Therapy & Infectious Diseases 5, 2021